Dr. Markus Glatzer
Oberarzt mbF
Radio-Onkologie · Dept. IV
Application of an IT knowledge base to improve decision-making for breast cancer in radiation oncology
07.03.2023
Klinische Forschung - 07.03.2023 - 30.09.2024
Laufend
Projektleitung: Dennstädt Fabio, Zink Johannes
Mitarbeiter/innen: Putora Paul Martin, Glatzer Markus, Plasswilm Ludwig
EORTC 1901-LCG PRIMALung Study
03.01.2022PRophylactic cerebral Irradiation or active MAgnetic resonance imaging surveillance in small-cell Lung cancer patients (PRIMALung study)
Klinische Forschung - 03.01.2022 - 03.11.2030
Geplant
Projektleitung: Putora Paul Martin
Mitarbeiter/innen: Glatzer Markus, Dennstädt Fabio
Role of Brachytherapy in the post-operative management of endometrial cancer: decision-making analysis among European experts“
04.02.2021To better understand decision-making processes for postoperative brachytherapy in endometrial cancer we want to initiate a project using an approach developed in our institution (objective consensus methodology) among European experts for this indica...
Klinische Forschung - 04.02.2021 - 31.10.2021
Automatisch geschlossen
Projektleitung: Glatzer Markus
Checkmate 73L (CA20973L)
01.01.2020A Phase 3, Randomized, Open Label Study to Compare Nivolumab plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Durvalumab in Previously Untreated, Locally A...
Klinische Forschung - 01.01.2020 - 11.12.2023
Laufend
Mitarbeiter/innen: Glatzer Markus
DOSIS RCT_Dose-intensified-Image-guided Fractionatet Stereotactic Body Radiation Therapy for Painful Spinal Metastasis versus Conventional Therapy: A Randomized Controlled Trial
03.07.2019Primary Objective: Randomised arm: To compare Long-term pain Response after dose- intensified imageguide hypofractioned SBRT employing SIB versus conventional Radiation therapy for painful spinal metastasis Prospective observational arm: To assess t...
Klinische Forschung - 03.07.2019 - 03.07.2024
Laufend
Projektleitung: Henke Guido
Mitarbeiter/innen: Panje Cédric, Glatzer Markus
EORTC 1702-LCG-ROG Targeted therapy with or without dose-intensified radiotterapy in oligo-progressive disease (OPD) in oncogene Addicted Lung Tumors
12.06.2019Targeted therapy beyond Progression with or without dose-intensified radiotHerapy in oligo-progressive disease (OPD) in oncogene Addicted Lung Tumors (HALT) Objectives: To determine wether in patients with Mutation positive advanced NSCLC the use of...
Klinische Forschung - 12.06.2019 - 01.02.2021
Automatisch geschlossen
Projektleitung: Glatzer Markus